Successful treatment with rituximab of refractory immune thrombocytopenic purpura
Idiopathic thrombocytopenic purpura (ITP) is a disorder characterized by accelerated destruction of platelets. About 25 to 30% of patients with ITP are resistant to standard treatment. Recent reports suggest that rituximab may be useful in treating chronic refractory ITP. We report a case of a 72-ye...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
SEEd
2009-12-01
|
| سلاسل: | Clinical Management Issues |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/543 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|